KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Acadia Pharmaceuticals (ACAD) Net Income towards Common Stockholders (2016 - 2025)

Acadia Pharmaceuticals has reported Net Income towards Common Stockholders over the past 16 years, most recently at $273.6 million for Q4 2025.

  • Quarterly results put Net Income towards Common Stockholders at $273.6 million for Q4 2025, up 90.32% from a year ago — trailing twelve months through Dec 2025 was $391.0 million (up 72.66% YoY), and the annual figure for FY2025 was $391.0 million, up 72.66%.
  • Net Income towards Common Stockholders for Q4 2025 was $273.6 million at Acadia Pharmaceuticals, up from $71.8 million in the prior quarter.
  • Over the last five years, Net Income towards Common Stockholders for ACAD hit a ceiling of $273.6 million in Q4 2025 and a floor of -$113.1 million in Q1 2022.
  • Median Net Income towards Common Stockholders over the past 5 years was -$6.7 million (2021), compared with a mean of $8.6 million.
  • Biggest five-year swings in Net Income towards Common Stockholders: crashed 139.49% in 2023 and later soared 2897.22% in 2024.
  • Acadia Pharmaceuticals' Net Income towards Common Stockholders stood at -$43.1 million in 2021, then increased by 3.28% to -$41.7 million in 2022, then skyrocketed by 209.88% to $45.8 million in 2023, then surged by 213.87% to $143.7 million in 2024, then soared by 90.32% to $273.6 million in 2025.
  • The last three reported values for Net Income towards Common Stockholders were $273.6 million (Q4 2025), $71.8 million (Q3 2025), and $26.7 million (Q2 2025) per Business Quant data.